1. Home
  2. SNT vs HRTX Comparison

SNT vs HRTX Comparison

Compare SNT & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Senstar Technologies Ltd.

SNT

Senstar Technologies Ltd.

HOLD

Current Price

$1.56

Market Cap

64.6M

ML Signal

HOLD

Logo Heron Therapeutics Inc.

HRTX

Heron Therapeutics Inc.

N/A

Current Price

$0.31

Market Cap

61.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SNT
HRTX
Founded
1965
1983
Country
Canada
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
64.6M
61.2M
IPO Year
2023
2007

Fundamental Metrics

Financial Performance
Metric
SNT
HRTX
Price
$1.56
$0.31
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$4.50
AVG Volume (30 Days)
6.9K
2.0M
Earning Date
04-23-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$154,904,000.00
Revenue This Year
N/A
$15.28
Revenue Next Year
N/A
$20.29
P/E Ratio
$19.22
N/A
Revenue Growth
N/A
7.36
52 Week Low
$1.59
$0.30
52 Week High
$5.34
$1.58

Technical Indicators

Market Signals
Indicator
SNT
HRTX
Relative Strength Index (RSI) 43.94 36.80
Support Level $1.59 $0.30
Resistance Level $1.89 $0.34
Average True Range (ATR) 0.07 0.02
MACD -0.00 0.00
Stochastic Oscillator 33.65 14.23

Price Performance

Historical Comparison
SNT
HRTX

About SNT Senstar Technologies Ltd.

Senstar Technologies Corp is an international provider of comprehensive physical, video, and access control security products and solutions. The company offers comprehensive solutions for critical sites, which leverage its broad portfolio of homegrown PIDS (Perimeter Intrusion Detection Systems), advanced VMS and SMS (Video Management Software and Security Management Software) with native IVA (Intelligent Video Analytics) security solutions, as well as access control products and technologies. Geographically, the company operates in North America, which derives maximum revenue; Europe; APAC; South and Latin America; and Others.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: